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Abstract 
MicroRNA (miRNA), a class of small, non-coding RNA - regulating post-transcriptionally protein 
expression - are emerging as clinical biomarkers in many pathologies, including cancer (Peng and 
Croce, 2016). Since miRNA are supposed to represent fundamental key regulators, better 
understanding of melanoma tumour biology is essential to improve both disease grading and staging 
and, consequently, therapy options and prognosis. The aim of the study was to investigate whether 
miRNA expression can vary in canine melanoma samples derived from formalin-fixed-paraffin-
embedded (FFPE) tissues. Experimental design of the study included three groups, each one 
composed of 7 animals: i) control healthy skin group ii) oral melanoma group iii) skin melanoma group. 
Two tissue slides were used for miRNA extraction. The expression levels of seven miRNA - miR-145, 
miR-146a, miR-425-5p, miR-223, miR-365, miR-155 and miR-134 - were detected and assessed by qPCR 
using TaqMan® probes (Veramo et al, 2017; Segura et al., 2012; Wagner et al., 2013; Sand et al.,2013). 
Five miRNA were significantly up-(n=3) or down-(n=2) regulated. In details, miR-146a and miR-155 
abundance was increased as compared with control in both oral and skin melanoma (Fig 1 B,E) (p = 
0.004 and 0.014 and p = 0.043 and 0.035 respectively), while the levels of miR-145 and miR-365 were 
lower (Fig 1 A,D) (p = 0.018 and 0.008 and p = 0.01 and 0.028, respectively). MiR-425-5p was 
upregulated (p = 0.039) only in skin melanoma (Fig. 1 C). Furthermore, functional analysis, carried out 
using miRNet web-based tool, showed that 76 genes related to cancer-associated pathways were 
possible target of these five microRNA (p = 6.95E-9); in particular, 21 target genes were associated 
with melanoma (p = 1.47E-5), including BRAF and CDK, E2F, FGF and PIK3 families. In conclusion, miR-
145, miR-146a, miR-425-5p, miR-365 and miR-155 are differentially expressed in melanoma and healthy 
FFPE samples, suggesting that they may play a role in canine melanoma pathogenesis and/or 
progression. 
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Fig 1: Boxplots of the median (black line), the mean (+), 25%- and 75%-quartile and range of the values measured, as well as 
statistical differences between groups are shown for miR-145, miR-146a, miR-425-5p, miR-365 and miR-155 in control, oral 
melanoma (oral M) and cutaneous melanoma (skin M) samples 
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